✦ LIBER ✦

The choice of the immunosuppressant for the patients of the malignant tumors after kidney transplantation

✍ Scribed by Haihao Wang; Weijie Zhang; Zhishui Chen; Qi Mei; Ke Ma

Publisher: Springer
Year: 2008
Tongue: English
Weight: 72 KB
Volume: 7
Category: Article
ISSN: 1610-1979
DOI: 10.1007/s10330-008-0042-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oxidative stress after kidney transplant

Oxidative stress after kidney transplantation: The role of immunosuppression

✍ Pavel Štrebl; Vladko Horčička Jr.; Karel Krejči; Pavel Horák; Jitka Vostálová; A 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 103 KB

## Abstract ## BACKGROUND Oxidative stress (OS) is one of the consequences of kidney transplantation (KT). The level of OS can be monitored using the total antioxidative status (TAS) and parameters that result from damaged molecules, such as advanced oxidation protein products (AOPPs). The aim of

Transplantation of human malignant tumor

Transplantation of human malignant tumors to the athymic rat

✍ Peter J. Dawson; Larry F. Kluskens; M. Joseph Colston; A. Howard Fieldsteel 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 926 KB

Defining the outcome of immunosuppressio

Defining the outcome of immunosuppression withdrawal after liver transplantation

✍ John Devlin; Derek Doherty; Linda Thomson; Terence Wong; Peter Donaldson; Bernar 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 216 KB

Successful immunosuppression withdrawal should benefit the natural history of organ transplantation patients. To identify the clinical hazards of removing drug treatment and possible characteristics that predict a favorable outcome in long-term liver recipients, immunosuppression was withdrawn compl

HLA-matched kidney transplantation in th

HLA-matched kidney transplantation in the era of modern immunosuppressive therapy

✍ Arun Amatya; Sandy Florman; Anil Paramesh; Anup Amatya; Jennifer McGee; Mary Kil 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 131 KB

Choice of the optimal dynamic conditions

Choice of the optimal dynamic conditions of irradiation of malignant tumors

✍ Yu. A. Oleinik-Ovod; L. Ya. Klepper 📂 Article 📅 1972 🏛 Springer US 🌐 English ⚖ 549 KB

Malignant rhabdoid tumor of the kidney:

Malignant rhabdoid tumor of the kidney: Involvement of chromosome 22

✍ Vandana Shashi; Mark A. Lovell; Christopher Von Kap-Herr; Peter Waldron; Wendy L 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 510 KB

Cytogenetic and molecular studies have demonstrated that involvement of 22q is a non-random finding in malignant rhabdoid tumors (MRTs) of the brain. We present an MRT of the kidney with the karyotype 47,XY,+i(l)(qlO), der(8)t(822)(q I2;q I I .2),der( 22)t(822)(q23 or q24. I ;q I I .2). This unbalan